July 19, 2024
Research Antibodies Market

Research Antibodies Market is Estimated To Witness High Growth Owing To Rising Focus On Therapeutic Antibodies Discovery

The Research Antibodies Market is estimated to be valued at US$ 3785.5 Bn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Research antibodies are tools used in biomedical research to detect, target, and quantify proteins and other biomarkers important in living systems. They are critical for fields like proteomics, neuroscience, immunology, and cancer research. Advancements in healthcare with greater focus on personalized medicine have increased the demand for research antibodies.

Market key trends:
One of the major trends driving the research antibodies market is the rising focus on therapeutic antibodies discovery. With growing prevalence of chronic diseases like cancer, therapeutic antibodies are gaining widespread importance. Based on their specificity and ability to stimulate immune responses, monoclonal antibodies are increasingly being explored for treating various conditions. Researchers are engaged in developing next generation therapeutic antibodies with improved potency and minimal side-effects. This is boosting investments in related research activities and antibodies required for early drug development stages.

Porter’s Analysis
Threat of new entrants: Low capital requirements and established brand loyalty in the market make entry difficult for new players.
Bargaining power of buyers: Large number of players in the market allows buyers to negotiate for better prices and quality.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to differentiated products and inputs required.
Threat of new substitutes: Minimal threat due to specialized manufacturing process and applications of research antibodies.
Competitive rivalry: High due to presence of major established global players.

SWOT Analysis
Strength:Specialized antibody development capabilities and global presence of major players. Product differentiation and brand recognition are other strengths.
Weakness: High R&D investment requirements and stringent regulatory norms. Dependency on limited number of suppliers for raw materials.
Opportunity: Growing biotechnology and pharmaceutical industries driving demand. Emerging markets offering new growth avenues.
Threats: Threat from biosimilars and alternate technologies. Economic slowdowns impacting research spending.

Key Takeaways
Global Research Antibodies Market Size is expected to witness high growth, exhibiting CAGR of 5.9% over the forecast period, due to increasing investments in R&D by pharma and biotech companies. The North American region accounted for over 35% market share in 2023 due to presence of leading players and availability of funding for research. Asia Pacific is expected to witness fastest growth owing to rising prevalence of chronic diseases and expanding biotech industry in countries like China and India.

Key players operating in the research antibodies market are Thermo Fisher Scientific Inc, Bio-rad Laboratories, Lonza Group, Merck Millipore, Cell Signalling Technology Inc., F.Hoffmann La Roche Ltd., Novartis AG, Takeda Pharmaceutical Company, Agilent Technologies, Danaher Corporation, BioLegend Inc., and Illumina. These players are focused on increasing Investments in antibody development and manufacturing capabilities to strengthen their market position.

1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it